FindTrial
Sign In

Homoeopathic medicines Cimicifuga racemosa and Sanguinaria canadensis in the treatment of Perimenopausal syndrome

Assessing the effectiveness of Homoeopathic medicines Cimicifuga racemosa and Sanguinaria canadensis in the management of Perimenopausal Syndrome - A comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102287
Enrollment
70
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: Cimicifuga racemosa and Sanguinaria canadensis: Study subjects who will be diagnosed with Perimenopausal Syndrome based on history clinical symptoms and Menopausal Rating Scale. These s

Sponsors

Dr Ananyaa A G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who are willing to participate as volunteers and who have signed the informed consent. Women diagnosed with perimenopausal syndrome. Women who are screened on the basis of Menopausal Rating Scale with a score 5 and above. Women between the age of 40-55 years.

Exclusion criteria

Exclusion criteria: Subject who had undergone artificial menopause by surgical or radiation therapy. Subjects with any diagnosed systemic illness.

Design outcomes

Primary

MeasureTime frame
Improvement in the symptoms of Perimenopausal Syndrome and Scores of Menopausal Rating ScaleTimepoint: 3 months—

Secondary

MeasureTime frame
Overall well being Sleep quality Emotional well beingTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Ananyaa A G

Government Homoeopathic Medical College and Hospital

renukasiddrampatil@gmail.com9945887471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026